Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Methodist Health System
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20%. Immunosuppression reduction is the management cornerstone for BKV and has been shown to be effective at clearing the virus while maintaining graft function in both kidney alone and simultaneous kidney-pancreas transplant recipients. However, there is a lack of published data on the prevalence and outcomes in simultaneous liver-kidney (SLK) transplant recipients.
Age
18–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years or older
SLK recipients transplanted at MDMC between 2015-2020
You may not be if
Below 18 years of age
Patients who did not undergo SLK transplant at MDMC
Clareo Health | Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
